{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/69097-431#drug","name":"Darifenacin","alternateName":"Darifenacin Hydrobromide","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"69097-431"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA207664"},{"@type":"PropertyValue","propertyID":"UNII","value":"CR02EYQ8GV"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"6e8470d1-c3e6-4644-b70a-aa47ddf79676"}],"activeIngredient":"DARIFENACIN HYDROBROMIDE","administrationRoute":["ORAL"],"dosageForm":"TABLET, EXTENDED RELEASE","manufacturer":{"@type":"Organization","name":"Cipla USA Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA207664","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e8470d1-c3e6-4644-b70a-aa47ddf79676","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-431"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T23:47:21.558Z"}}